Relationships Between Clinical Behavior of Laryngeal Squamous Cell Carcinomas and Expression of VEGF, MMP-9 and E-Cadherin

Abstract

The biological mechanisms of cancer and associations with behavior of tumours need to be studied to understand progression and determine appropriate treatments. Here we investigated expression of VEGF, MMP-9 and E-cadherin in laryngeal SCCs and their relations with clinical behavior. This prospective study was based on 38 surgical specimens from patients with primary laryngeal SCC and data recorded in their cards. Expression of the three factors in tumor tissue was examined using immunohistochemistry and correlations with clinical parameters of primary tumors, regional lymph node metastases, stage of disease, histopathologic differentiation, and vascular/cartilage invasion were investigated. Regarding the cases with positive MMP-9 expression, the difference between well and moderately/poorly differentiated tumors was statistically significant. However, differences between early stage (stage I and II) and late-stage (stage III and IV) tumours, and between positive and negative for pLN metastasis were not. No significant relationship between positive VEGF and tumor differentiation or stage was apparent, but E-cadherin levels significantly differed between well and moderately/ poorly differentiated tumours and with the presence of pLN metastasis. E-cadherin staining did not vary between MMP-9 positive and negative cases. In conclusion, MMP-9 may be a negative predictor of differentiation in laryngeal SCC, while E-cadherin is a predictor of differentiation and nodal metastases. Even if the difference between VEGF expression and tumor stage was not statistically significant, it seems that there exists some relationship, which might be clarified with a greater number of cases.

Cinobufacin Suppresses Cell Proliferation via miR-494 in BGC-823 Gastric Cancer Cells

“…Many studies have demonstrated that MMP-9 (Hassan et al, 2012;Zhang et al, 2012;Akdeniz et al, 2013;Asuthkar et al, 2013;Darakhshan et al, 2013;Li et al, 2013), ERK1/2 (Romano et al, 2012), KIT (Kim et al, 2011) and PTEN are considered to be the potential targeted genes of miR-494. In present study, BAG-1 is predicted as the targeted gene of miR-494 by using bioinformatics tools TargetScan, PicTar, and Miranda.…”

Serum Vascular Endothelial Growth Factor-A (VEGF-A) as a Biomarker in Squamous Cell Carcinoma of Head and Neck Patients Undergoing Chemoradiotherapy

“…VEGF is a multifunctional cytokine that exerts a variety of effects on vascular endothelial cells that together promote the formation of new blood vessels, increases vascular endothelial permeability, stimulates the proliferation of endothelial cells and promote cancer cell progression (Dvorak, 2002;Mohammed et al, 2007;Niu et al, 2010;Akdeniz et al, 2013;Huang et al, 2013;Zhang et al, 2013). In particular, serum VEGF-A levels are elevated in patients with HNSCC compared to healthy controls (De Schutter et al, 2005;Hong et al, 2009;Liang et al, 2013).…”

Study of the Histopathologic Characteristics and Surface Morphologies of Glottic Carcinomas With Anterior Vocal Commissure Involvement

“…The tumoral involvement of the cartilage is thought to be promoted by the chemotactic effect of vascular endothelial growth factor. 19 The ossification of the thyroid cartilage is another reason for cartilage involvement. The ossification of the ITC occurs in front of the LTC due to the insertion, the pulling from the vocal muscles, and the cartilage angle.…”